MabVax Discovery Platform
We have developed a proprietary approach to the discovery and development of novel fully human antibody therapies and diagnostic agents.
View PlatformHome
Clinical Development
Our portfolio includes fully human antibodies that are being developed to address unmet medical needs in several difficult to treat cancers such as pancreatic, lung, sarcoma, ovarian, and breast cancer.
View Product PipelineInvestor Relations
MabVax Therapeutics Holdings, Inc.
NASDAQ: MBVX
Price
Change
Volume
Day Range
52 Week Range
Company Profile
MabVax Therapeutics Holdings, Inc. a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical development of products to address unmet medical needs for the treatment of cancer.
View Investors Relations
